BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25506828)

  • 1. Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice.
    Boesjes M; Bloks VW; Hageman J; Bos T; van Dijk TH; Havinga R; Wolters H; Jonker JW; Kuipers F; Groen AK
    PLoS One; 2014; 9(12):e115028. PubMed ID: 25506828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
    Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
    J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.
    Ramos Pittol JM; Milona A; Morris I; Willemsen ECL; van der Veen SW; Kalkhoven E; van Mil SWC
    Gastroenterology; 2020 Nov; 159(5):1853-1865.e10. PubMed ID: 32712104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.
    Zhang Y; Kast-Woelbern HR; Edwards PA
    J Biol Chem; 2003 Jan; 278(1):104-10. PubMed ID: 12393883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
    Lukovac S; Los EL; Stellaard F; Rings EH; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G520-31. PubMed ID: 19608735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
    Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice.
    Herrema H; Meissner M; van Dijk TH; Brufau G; Boverhof R; Oosterveer MH; Reijngoud DJ; Müller M; Stellaard F; Groen AK; Kuipers F
    Hepatology; 2010 Mar; 51(3):806-16. PubMed ID: 19998408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.
    Song X; Chen Y; Valanejad L; Kaimal R; Yan B; Stoner M; Deng R
    J Lipid Res; 2013 Nov; 54(11):3030-44. PubMed ID: 24002920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXR, a multipurpose nuclear receptor.
    Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver receptor homolog-1 is critical for adequate up-regulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration.
    Out C; Hageman J; Bloks VW; Gerrits H; Sollewijn Gelpke MD; Bos T; Havinga R; Smit MJ; Kuipers F; Groen AK
    Hepatology; 2011 Jun; 53(6):2075-85. PubMed ID: 21391220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
    Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia.
    Heidker RM; Caiozzi GC; Ricketts ML
    Mol Nutr Food Res; 2016 Apr; 60(4):727-36. PubMed ID: 26718753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.
    Porez G; Gross B; Prawitt J; Gheeraert C; Berrabah W; Alexandre J; Staels B; Lefebvre P
    Endocrinology; 2013 Oct; 154(10):3690-701. PubMed ID: 23861371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
    Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
    Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
    Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
    Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
    Singh AB; Dong B; Xu Y; Zhang Y; Liu J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):358-371. PubMed ID: 30580099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.